| Product Code: ETC319647 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Singapore colistin market involves antibiotics used in healthcare to combat bacterial infections. Colistin has gained prominence due to its effectiveness against multidrug-resistant bacteria. Its use is carefully regulated to prevent antibiotic resistance. The market primarily consists of pharmaceutical companies manufacturing colistin-based medications, and healthcare professionals prescribing them. Singapore places a strong emphasis on antimicrobial stewardship to ensure responsible use.
The colistin market in Singapore is driven by the healthcare sector`s demand for antibiotics, particularly in the treatment of multidrug-resistant bacterial infections. Colistin, despite its side effects and limited use due to resistance concerns, remains a vital option in certain clinical scenarios. The increasing incidence of drug-resistant bacteria and the need for effective treatments in critical care settings contribute to the demand for colistin. The healthcare system`s preparedness for infectious disease outbreaks also fuels the stockpiling and availability of colistin as a therapeutic option.
The Singapore Colistin market faces several challenges, primarily stemming from the growing concern over antibiotic resistance. Colistin, an antibiotic of last resort, has been increasingly used in healthcare and agriculture. However, its use has led to the development of resistant strains of bacteria, posing a severe threat to public health. Regulatory restrictions and stringent guidelines on colistin use are being implemented to address this issue. Additionally, the market faces challenges in terms of production costs and the search for alternative antibiotics.
The COVID-19 pandemic had limited direct impact on the colistin market in Singapore. Colistin is an antibiotic primarily used to treat bacterial infections, and its demand remained relatively stable during the pandemic. However, the broader context of the pandemic, including increased antibiotic use and potential antibiotic resistance concerns, highlighted the importance of responsible antibiotic stewardship in healthcare settings, which could have downstream implications for the colistin market.
In the Singapore colistin market, pharmaceutical companies like AstraZeneca and Pfizer are involved in the production and distribution of antibiotics, including colistin, which is used in the treatment of bacterial infections.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Singapore Colistin Market Overview |
3.1 Singapore Country Macro Economic Indicators |
3.2 Singapore Colistin Market Revenues & Volume, 2021 & 2031F |
3.3 Singapore Colistin Market - Industry Life Cycle |
3.4 Singapore Colistin Market - Porter's Five Forces |
3.5 Singapore Colistin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Singapore Colistin Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Singapore Colistin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of multidrug-resistant bacteria in Singapore |
4.2.2 Growing awareness about the importance of appropriate antibiotic use |
4.2.3 Rising healthcare expenditure and investments in healthcare infrastructure in Singapore |
4.3 Market Restraints |
4.3.1 Strict regulations and policies related to antibiotic use and prescription in Singapore |
4.3.2 Availability of alternative antibiotics and treatments for bacterial infections |
5 Singapore Colistin Market Trends |
6 Singapore Colistin Market, By Types |
6.1 Singapore Colistin Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Singapore Colistin Market Revenues & Volume, By Product Type, 2021-2031F |
6.1.3 Singapore Colistin Market Revenues & Volume, By API, 2021-2031F |
6.1.4 Singapore Colistin Market Revenues & Volume, By Premix, 2021-2031F |
6.1.5 Singapore Colistin Market Revenues & Volume, By Others, 2021-2031F |
6.2 Singapore Colistin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Singapore Colistin Market Revenues & Volume, By Pig, 2021-2031F |
6.2.3 Singapore Colistin Market Revenues & Volume, By Chicken, 2021-2031F |
6.2.4 Singapore Colistin Market Revenues & Volume, By Other, 2021-2031F |
7 Singapore Colistin Market Import-Export Trade Statistics |
7.1 Singapore Colistin Market Export to Major Countries |
7.2 Singapore Colistin Market Imports from Major Countries |
8 Singapore Colistin Market Key Performance Indicators |
8.1 Rate of antibiotic-resistant infections in Singapore |
8.2 Number of research and development initiatives focused on new antibiotics in Singapore |
8.3 Level of adherence to antibiotic stewardship programs in healthcare facilities in Singapore |
9 Singapore Colistin Market - Opportunity Assessment |
9.1 Singapore Colistin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Singapore Colistin Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Singapore Colistin Market - Competitive Landscape |
10.1 Singapore Colistin Market Revenue Share, By Companies, 2024 |
10.2 Singapore Colistin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |